Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling
Ladislav Sivák, Vladimír Šubr, Jiřina Kovářová, Barbora Dvořáková, Milada Šírová, Blanka Řı́hová, Eva Randárová, Michal Kraus, Jakub Tomala, Martin Studenovský, Michaela Vondráčková, Radislav Sedláček, Petr Makovický, Jitka Fučíková, Šárka Vošáhlíková, Radek Špíšek, Libor Kostka, Tomáš Etrych, Marek Kovář
Topics & Concepts
In vivoChemistryPharmacologyRitonavirBortezomibIn vitroCancer researchBiochemistryMedicineBiologyVirologyImmunologyMultiple myelomaAntiretroviral therapyBiotechnologyHuman immunodeficiency virus (HIV)Viral loadHIV/AIDS drug development and treatmentPeptidase Inhibition and AnalysisPneumocystis jirovecii pneumonia detection and treatment